Full-Time

Associate Director

Computational Immunology

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Mid, Senior

Boston, MA, USA

Hybrid position.

Category
Computational Biology
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Agile
Python
R
SQL
Data Analysis
Requirements
  • PhD degree in a quantitative discipline (e.g. Computational Biology, Cancer Biology, Computational Immunology, Biostatistics/Statistical Genetics, Bioinformatics, or similar). Alternatively, a PhD in Molecular Biology or Immunology combined with a very strong record in computational biology.
  • Minimum 4+ years in drug development leveraging genomic and multimodal data for drug discovery and development.
  • Proficient in R, Python, and SQL.
  • Strong understanding of Cancer, Immunology, Clinical Trials, and Real-World Evidence Platforms.
  • Extensive prior experience analyzing genomic data, including whole exome sequencing, whole transcriptome sequencing, TCR/BCR immune repertoire sequencing, and particularly single-cell RNA sequencing.
  • Demonstrated ability to lead cross-functional agile teams and manage complex projects.
  • Strong strategic thinking and problem-solving skills.
  • Excellent written and verbal communication skills, with the ability to present complex information clearly and persuasively to diverse audiences.
  • Ability to build strong positive relationships with internal and external stakeholders.
  • Collaborative and team-oriented with a high degree of emotional intelligence and strong negotiation and mentorship skills.
Responsibilities
  • Lead a dynamic team of computational scientists executing Translational or Real-World Evidence projects integrating molecular and clinical data from Tempus’ multimodal data platform to derive insights for biopharma partners.
  • Establish best practices for reproducibility, help identify analytical gaps, and suggest next steps.
  • Design, develop, and execute computational immunology research projects of high complexity.
  • Support exploratory research for target discovery and validation in pre-clinical and early phases of drug development.
  • Support decisions for early-stage assets such as patient and indication selection, biomarker, and combination strategies.
  • Evaluate clinical trial design by testing assumptions, refining eligibility criteria, and characterizing patient outcomes on standard of care.
  • Work closely with internal teams, including key account directors, business development, operations, alliance management, and research informatics, to align team initiatives with broader business goals.
  • Support the development of specific account strategies in coordination with the account team to expand accounts into strategic collaborations.
  • Oversee the generation of contracted deliverables and executive summaries for biopharma customers.
  • Collaborate with external partners to establish Tempus as a trusted advisor to expand research partnerships.
  • Work closely with the alliance manager for the execution, and deliverables of research projects, ensuring that they are completed on time, within budget, and in accordance with contracted specifications.
  • Stay current with industry trends, best practices, and advancements in computational oncology research.
  • Apply this knowledge to enhance research methodologies and improve overall research quality on the team.
  • Become an expert in our biopharma partners’ strategy, pipeline, and portfolio to proactively determine all areas in the Tempus platform that could add value to the drug development process of our partners.
  • Work with Product and Engineering teams to streamline the workflow of computational analyses.
  • Build relationships with R&D and commercial executives internally and at partner organizations, enabling identification, development of, and support for additional value-creation opportunities.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where they have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Unlike many competitors, Tempus combines extensive research with practical applications in patient care and drug development. The goal of Tempus is to improve healthcare delivery and outcomes by leveraging advanced data analysis and AI.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

4%

1 year growth

13%

2 year growth

34%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.

Help us improve and share your feedback! Did you find this helpful?